DocuSign Inc (DOCU)
Official siteTECHNOLOGY • SOFTWARE - APPLICATION • NASDAQ
Market Cap: $14.92B
Last updated: Nov 17, 2026 at 4:41 PM ET
DocuSign Inc (DOCU) Stock Chart
DocuSign (DOCU) has a latest price of $75.93 on Nov 17, 2026, 11.6% below its 52-week high of $85.90. Its price rose 12.1% over the past 12 months. The month-end price rose 112.7% since Apr 2018, a compound annual rate of 9.3%.
Price Chart
From Apr 2018 to Oct 2026, its highest month-end close was $298.04 in Jul 2021 and its lowest $38.63 in Apr 2018, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart DOCU with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for DOCU.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 22.3%, and over 6 months it rose 53.6%. The month-end price rose 111.3% over the 3 years through Oct 2026, a compound annual rate of 28.3%.
| Period | Change |
|---|---|
| 1 month | -1.0% |
| 3 months | +22.3% |
| 6 months | +53.6% |
| 12 months | +12.1% |
| 12 months, with dividends | +12.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +111.3% | +28.3% |
| 5 years | -70.5% | -21.6% |
| Since Apr 2018 | +112.7% | +9.3% |
Price by Year
Its best calendar year was 2020, when the price rose 200.0%, and its weakest was 2022, when it fell 63.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $82.17 | +20.1% |
| 2025 | $68.40 | -23.9% |
| 2024 | $89.94 | +51.3% |
| 2023 | $59.45 | +7.3% |
| 2022 | $55.42 | -63.6% |
| 2021 | $152.31 | -31.5% |
| 2020 | $222.30 | +200.0% |
| 2019 | $74.11 | +84.9% |
Trading Range
The price is 2.0% above its 50-day average of $74.45 and 35.6% above its 200-day average of $55.98.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $75.93 | |
| 52-week high | $85.90 | -11.6% |
| 52-week low | $40.16 | +89.1% |
| 50-day average | $74.45 | +2.0% |
| 200-day average | $55.98 | +35.6% |
Price Risk
Over 3 years, its largest fall from a peak was 61.0%.
| Measure | Value |
|---|---|
| 1-year beta | 0.44 |
| Largest fall, 1 year | -41.3% |
| Largest fall, 3 years | -61.0% |
Valuation
DocuSign traded at 18.5x earnings at the end of 2025, against a 5-year median of 21.0x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About DOCU
What is DOCU's 1-year price change?
DocuSign's price rose 12.1% over the past 12 months. With dividends included, the 12-month total return was 12.1%.
What is DOCU's 5-year price change?
DocuSign's month-end price fell 70.5% over the 5 years through Oct 2026, a compound annual decline of 21.6%. These figures leave out dividends.
What is DOCU's 52-week high and low?
DocuSign's 52-week high is $85.90 and its 52-week low is $40.16. Its latest price of $75.93 on Nov 17, 2026 is 11.6% below the high.
What is DOCU's beta?
DocuSign's 1-year beta against the S&P 500 is 0.44, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 41.3%.
Is the DOCU chart free?
Yes. Advanced Charting for DOCU is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
DOCU pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors